e incidence and risk factors of venous thromboembolism in Iranian inpatients with inflammatory bowel disease: a retrospective cohort study.

Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 397

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

CANCERMED04_007

تاریخ نمایه سازی: 17 مرداد 1398

Abstract:

BACKGROUND: Venous thromboembolism (VTE) is a major extraintestinal manifestation in inflammatory bowel disease (IBD), regarded as an independent risk factor for VTE according to reports from Western countries. However, the incidence and risk factors of VTE in Asian IBD patients are not fully understood. We aimed to reveal the incidence and risk factors of VTE in iranian IBD inpatients. METHODS: The incidence of VTE in inpatients with IBD (n=420), gastrointestinal cancers (n=610), and other gastrointestinal diseases (n=583) treated at our hospital from 2012 to 2018 was retrospectively investigated. The characteristics and laboratory data of IBD inpatients with and without VTE were compared in univariate and multivariate analyses. Clinical courses of VTE in IBD were surveyed. RESULTS: VTE was detected in 7.7% of IBD inpatients, significantly higher than in gastrointestinal cancer inpatients (2.9%) and inpatients with other gastrointestinal diseases (0.83%). The incidence of VTE in ulcerative colitis (UC) patients (16.4%) was much higher than that in those with Crohn s disease (3.9%). In the univariate analysis, the risk factors were an older age, central venous catheter, prednisolone, surgery, low serum albumin, high serum C-reactive protein and D-dimer. According to a multivariate analysis, > 50 years of age and surgery were the only risk factors. The in-hospital mortality rate of IBD inpatients with VTE was 4.5%. CONCLUSIONS: The incidence of VTE with IBD, especially UC, was found to be high compared with other digestive disease, which was almost equivalent to that of Western countries. The efficacy of prophylaxis needs to be investigated in Asian IBD patients.

Authors

Seyed Ehsan Asadi

PHD of Nursing,Isfahan .Iran

Ali Bagheri

Internal medicine specialist,Isfahan .Iran.

Elahe Mohtasham

fery expert. Isfahan .Iran.

Ahmad Rahimi

Nursing Student,Isfahan .Iran